Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Letfem Tablet

Prescription Icon
Prescription Required

Marketer

Neon Laboratories Ltd

Salt Composition

Letrozole (2.5mg)

Overview Letfem Tablet

Postmenopausal women with breast cancer may find relief with Letfem Tablets. This medication can be a standalone treatment or used alongside surgery or radiation therapy. For those with advanced breast cancer, Letfem Tablets can help prevent metastasis. Administration is flexible—with or without food—always adhering to the physician's prescribed dosage and duration for optimal results. Dosage frequency is determined by the specific treatment goal, with your doctor adjusting the regimen to manage your symptoms effectively. Consistent use, as directed, is crucial. Common side effects include increased perspiration, fatigue, hot flashes, and elevated cholesterol. Report any concerning or persistent side effects immediately to your physician, who can offer mitigation strategies. Prior to commencing Letfem Tablet therapy, inform your doctor of any pre-existing liver or kidney conditions, or history of osteoporosis. Complete disclosure of all other medications is essential, as interactions can affect Letfem's efficacy. Furthermore, pregnant or breastfeeding women must consult their doctor before using this medication. Your doctor might order blood tests to monitor vitamin D levels and bone density before and throughout your treatment.

Uses of Letfem Tablet

Managing breast cancer

Major Benefits of Letfem Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letfem Tablet can be consumed with or without food, however, consistent timing is recommended.

Common Side effects of Letfem Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letfem Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letfem Tablets can be consumed with or without food, though consistent timing is recommended.

How Letfem Tablet works:

Letfem Tablets function as an aromatase inhibitor, reducing the body's estrogen production. This lowered estrogen level can impede or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Letfem Tablet's concurrent use with alcohol does not produce adverse reactions.

PregnancyPregnancyUNSAFE

Using Letfem Tablet during pregnancy poses a significant risk. Pregnant individuals should consult their physician; research in animal and human studies indicates substantial harm to the fetus.

Breast feedingBreast feedingUNSAFE

Lactation and Letfem Tablet use are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking Letfem Tablets may cause drowsiness, blurred vision, or dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Renal impairment does not necessitate a Letfem Tablet dosage change; its use is considered safe in such patients. However, data on its use in end-stage renal disease is scarce. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Letfem Tablet, as dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take Letfem Tablet :

Should you forget a Letfem Tablet dose, take it immediately. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Letfem Tablet

LabelValue
Chemical Classification Diphenylmethane-based compound
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Letfem Tablet

Letfem tablets are used to treat breast cancer in postmenopausal women. This aromatase inhibitor is typically prescribed for women who have stopped menstruating, whether naturally, surgically, or due to chemotherapy.
Letfem tablets are anti-estrogens, meaning they lower the body's estrogen levels. This occurs by inhibiting the aromatase enzyme, responsible for estrogen production. Estrogen fuels the growth of certain breast cancers, known as estrogen-dependent cancers. Lowering estrogen levels can therefore hinder cancer growth.
For advanced breast cancer or cancer that has spread, continue Letfem Tablet treatment until tumor progression. Following tamoxifen or surgery, Letfem Tablet should be taken for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Letfem Tablet followed by three years of tamoxifen may be used.
It's safe to take irbesartan and Letfem Tablet concurrently, but monitor your blood pressure closely as Letfem Tablet can elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Letfem Tablet may cause cataracts. Report blurred vision or eye irritation to your doctor promptly.
Letfem Tablet may cause hot flushes, a common side effect resulting from lowered estrogen levels. These typically lessen as your body adapts, though some women experience them throughout and for a few months after treatment. If hot flushes are severe, consult your doctor for management options.
Letfem Tablet's serious side effects—stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions—are rare.
Letfem Tablet can weaken bones (osteoporosis) by lowering estrogen levels. Your doctor may monitor your bone density before, during, and after treatment to check for this.
The Ministry of Health and Family Welfare restricts Letfem Tablet use to ovulation induction in women with anovulatory infertility.
Letfem Tablet
27
MRP 31
12% off